Home

Ra Capital Management, Director: Climb Bio CLYM Buy · Filed 24/07/01

Trade details

Type
Insider buy
Amount
$4,068,000
Shares · price
1,059,375 sh · $3.84 a share
Held after
2,866,375 sh
Trade date
24/06/27
Filed
24/07/01
Days to filing
4 days

First buy since 2023

Insiders buying this week
7 insiders
Holding change
+58.6%

Climb Bio trades, last 26 weeks

What else happened in Climb Bio around then

Filed or reported within 30 days of the trade day · 24/05/28~24/07/27

Ra Capital Management's recent trades

  • Ra Capital Management

    BuyArtiva Biotherapeutics

    $275.3K

    Filed 06/29

  • Ra Capital Management

    BuyArtiva Biotherapeutics

    $16.8K

    Filed 06/29

  • Ra Capital Management

    SellWerewolf Therapeutics

    $136.2K

    Filed 06/22

  • Ra Capital Management

    SellWerewolf Therapeutics

    $9,693

    Filed 06/22

  • Ra Capital Management

    BuyHemab Therapeutics Holdings

    $1.5M

    Filed 06/17

Ra Capital Management, Director — bought $4.1M of Climb Bio CLYM · 1,059,375 sh @ $3.84 | Whalegun